Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • The Pharma 50

U.S. government on the hook for COVID-19 vaccine liability

By Brian Buntz | April 14, 2021

COVID-19 vaccines NIH

[Image by Sam Moqadam on Unsplash]

There have multiple surges in malpractice claims following each wave of COVID-19 infections.

According to Victor Bornstein, CEO of Justpoint (New York City), the vast majority of those claims have targeted medical malpractice, an AI company specializing in malpractice. “The healthcare system was under a lot of stress, and more mistakes tend to happen,” Borstein said.

There hasn’t been a surge in cases related to the pandemic against pharmaceutical companies, whose COVID-19 therapies are legally shielded from lawsuits.

But the FDA’s and CDC’s joint decision to pause the use of Johnson and Johnson’s COVID-19 vaccine could lead to renewed focus on potential adverse events linked to COVID-19 vaccines.

Pharmaceutical companies themselves “cannot be sued for money damages in court” over possible injuries related to COVID-19 vaccines or therapeutics.

COVID-19 vaccines and therapeutics are, however, covered under the U.S. government’s Countermeasures Injury Compensation Program (CICP).

The program has “strict criteria,” Bornstein said.

“If someone had an issue with a COVID-19 vaccine, it’s going to be complicated for them” to be compensated, Bornstein concluded.

For one thing, payouts are limited in size.

“There’s also the question of causation,” Bornstein said. While events like anaphylaxis are relatively simple to associate with a vaccine, many side effects aren‘t. “In general medical practice, it’s easier to understand [adverse events] because you have more medical records,” he added.

But if someone who receives a vaccine develops, for instance, Bell’s palsy, it can be challenging to prove causation as the condition itself is idiopathic.

“In cases like this, the lawyers who get involved do research. It almost becomes like a scientific study,” Bornstein said. “The question becomes: ‘Are attorneys confident they will receive a payout after engaging in such extensive research?’”

But if a side effect occurs more often in the population who has received a vaccine, it is important for those experiencing the adverse events to document it. “The overall population needs to know,” Bornstein said.

“What we do know is that COVID kills,” Bornstein said. And the more people who receive the vaccine, the more functional immunity will exist across society, which will translate into fewer deaths in the long run.

Understanding the ultimate benefit-risk ratio for COVID-19 vaccines and therapeutics is a more significant undertaking, Bornstein said. “These things take time.”


Filed Under: Infectious Disease
Tagged With: adverse events, coronavirus, covid-19, COVID-19 vaccine, liability
 

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Related Articles Read More >

Pfizer-BioNTech
FDA allows booster dose Pfizer-BioNTech COVID-19 vaccine in children 5 to 11
AstraZeneca RQ Biotechnology
AstraZeneca paying up to $157M for broad-spectrum monoclonal antibodies against COVID
NIH National Institutes of Health
NIH licenses COVID-19 research technologies to WHO initiative
Olumiant
FDA approves Olumiant for treating some hospitalized COVID-19 patients

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • The Pharma 50